Study of the compatibility of oral magnesium oxide preparations sold in Japan with the ICH-Q3D guideline for elemental impurities

Satoh M, Motokawa K, Uesawa Y, Ishikawa Y, Maeda H, Iida K, Tanaka H, Kosugi T, Nishizawa K

Drug Discov Ther. 2021; 15(5):227-235.

DOI: 10.5582/ddt.2021.01078

Summary Full Text (PDF)

Catheter failure in the administration of hyperosmotic drugs through a peripheral vein and vascular selection: A retrospective cohort study

Takahashi T, Murayama R, Abe-Doi M, Miyahara M, Kanno C, Nakagami G, Sanada H

Drug Discov Ther. 2021; 15(5):236-240.

DOI: 10.5582/ddt.2021.01080

Summary Full Text (PDF)

Physicochemical properties of brand and generic infusion fluid preparations (Part 3): Investigation of type 1 hypotonic infusion fluids

Takei S, Katsuyama S, Hori Y

Drug Discov Ther. 2021; 15(5):241-247.

DOI: 10.5582/ddt.2021.01083

Summary Full Text (PDF)

Electrolytic-reduction ion water induces ceramide synthesis in human skin keratinocytes

Yamamoto H, Ikeda M, Okajima Y, Okajima M

Drug Discov Ther. 2021; 15(5):248-253.

DOI: 10.5582/ddt.2021.01091

Summary Full Text (PDF)

Post COVID-19 sequelae: A prospective observational study from Northern India

Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, Desai D, Trilangi PK, Chakraborty S, Begam NN, Bhattacharya B, Maher G, Mahishi N, Rajanna C, Kumar SS, Arunan B, Kirtana J, Gupta A, Patidar D, Kodan P, Sethi P, Ray A, Jorwal P, Kumar A, Nischa

Drug Discov Ther. 2021; 15(5):254-260.

DOI: 10.5582/ddt.2021.01093

Summary Full Text (PDF)

Association of bleeding symptoms during influenza infection and administered drugs

Sugawara T, Ohkusa Y, Taniguchi K, Miyazaki C, Kato Y, Okabe N

Drug Discov Ther. 2021; 15(5):261-267.

DOI: 10.5582/ddt.2021.01085

Summary Full Text (PDF)

Antiviral effect of electrolyzed reduced water on SARS-CoV-2

Okajima Y, Okajima M, Ikeda M, Wada Y, Shimokawa K, Ishii F

Drug Discov Ther. 2021; 15(5):268-272.

DOI: 10.5582/ddt.2021.01092

Summary Full Text (PDF)

Role of systemic corticosteroids in preventing hypoxia among patients with mild COVID-19: An observational study

Aggarwal A, Mittal A, Soneja M, Shankar SH, Naik S, Kodan P, Nischal N , Jorwal P, Ray A, Wig N

Drug Discov Ther. 2021; 15(5):273-277.

DOI: 10.5582/ddt.2021.01081

Summary Full Text (PDF)

Does immunosuppressive property of non-steroidal antiinflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects?

Kazama I, Senzaki M

Drug Discov Ther. 2021; 15(5):278-280.

DOI: 10.5582/ddt.2021.01094

Summary Full Text (PDF)